A detailed history of Smithfield Trust CO transactions in Catalent, Inc. stock. As of the latest transaction made, Smithfield Trust CO holds 140 shares of CTLT stock, worth $8,887. This represents 0.0% of its overall portfolio holdings.

Number of Shares
140
Previous 140 -0.0%
Holding current value
$8,887
Previous $8,000 12.5%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2023

SELL
$31.86 - $67.26 $1,115 - $2,354
-35 Reduced 20.0%
140 $6,000
Q3 2020

Nov 16, 2020

BUY
$72.74 - $92.5 $6,546 - $8,325
90 Added 105.88%
175 $15,000
Q2 2020

Aug 14, 2020

BUY
$48.02 - $79.04 $4,081 - $6,718
85 New
85 $6,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Smithfield Trust CO Portfolio

Follow Smithfield Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smithfield Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Smithfield Trust CO with notifications on news.